Birgen Meuleman has a Master in Biological Science and over the past 15 years gained progressively experience in Clinical Development.
His career developed in both a CRO environment (Harrison Clinical Research) as well as in medium-sized biotech (Movetis, Tibotec) and large pharmaceutical companies (Shire, Johnson & Johnson). With his refined project and vendor management skills, Birgen successfully managed smaller proof-of-concept studies as well as global pivotal trials leading to drug registration. In his current role as Clinical Program Leader, he strives for efficiency by optimizing operating processes and by maximising collaborators’ engagement while safeguarding timelines, quality and budget.
As managing partner, Birgen, is overlooking the finances and administrative operations within 2 Bridge. Besides his skills to work with figures, he enjoys interacting swiftly with all layers within an organization, which builds bridges between leadership teams and collaborators, between internal and external partners.